Panalgo, a leading healthcare analytics company, today announced that its Instant Health Data (IHD) platform will be used by the European Medicines Agency (EMA) to facilitate the analysis of real-world data. EMA will use IHD to undertake rapid analyses of Electronic Healthcare Data (EHDs) […]
Tracing the Health Care Experience Informs Decision-making
Mapping the patient journey is a worthwhile exercise to undertake because it answers critical questions of interest to all health care stakeholders. The richness of patient journey mapping can help develop patient cohorts and assess effectiveness of therapeutics. Total health care utilization and […]
Why Population Health Isn’t the ‘Virtuous’ Approach
Mark Ganz isn't a fan of healthcare's fixation on population health. Ganz, who recently left the role of CEO of Cambia Health Solutions, told Fierce Healthcare in a recent interview that looking at health through a population lens creates distance between the healthcare system and the patient […]
Driving More Value and Cost Savings With SDOH Data
Getting a Social Determinant of Health (SDOH) initiative off the ground requires thoughtful coordination and analysis between analytics teams, clinicians, social workers and others, and buy-in from leadership. SDOH data includes details about income, education, race, gender and other social factors. […]
ICER Seeks Applications for New Health Technology Assessment Fellowship
The Institute for Clinical and Economic Review (ICER) is now accepting applications for the inaugural cycle of a new Health Technology Assessment (HTA) Fellowship. The ICER HTA Fellowship is a paid full-time one-year program for post-master's and post-doctoral graduates that provides experiential […]
RxSense Joins with Hy-Vee to Launch New PBM Vivid Clear Rx
RxSense was founded in 2015 with a singular focus on developing technology solutions that improve healthcare transparency and access to more affordable medications. RxSense also utilizes its advanced platform and direct contracts with the nation’s largest pharmacies (including CVS, Walmart and […]
Healthcare Venture Launched by Amazon, JPMorgan and Berkshire Hathaway Goes Bust
Haven—the healthcare company formed by Amazon, JPMorgan Chase and Berkshire Hathaway—is apparently no more. The healthcare company began telling employees on Monday about plans to shut down by the end of next month, CNBC reported first on Monday morning. Haven was first announced in January 2018 as […]
Hospitals Lose Another Attempt to Stave Off Price Transparency
A federal appeals court ruled against hospitals' efforts to stop regulators from forcing them to reveal the secret negotiated prices they reach with insurers, according to an opinion filed Tuesday. Hospitals were hoping for intervention from the D.C. Circuit Court of Appeals as the rule requires […]
How Does Cost-Sharing Impact Spending Growth and Cost-Effective Treatments?
The growth of health care spending has been a longstanding policy concern. Over the years, several innovations have been proposed to lower levels of health care spending; however, their impact has been limited and not sustained over time. Costly new technology, while often an improvement to existing […]
Impact of the Pandemic on Medical and Scientific Affairs
In the latest episode of Impetus Digital's Fireside Chat, Dr. Shurjeel Choudhri, SVP and Head, Medical and Scientific Affairs, Bayer Canada, joins me for a wide-ranging conversation on several hot topics in Pharma and healthcare. Among many other things, we explore innovative digital technologies, […]
The Medical Science Liaison-DISC Personality Types Survey
The MSL role is constantly evolving and facing new challenges. MSLs are both scientific experts and relationship managers. As such, they are required to perform tasks that are extremely analytical and technical in nature, while being able to skilfully handle relationships on a human level. Each of […]
Trends That Matter for COVID Vaccine Distribution
As details continue to emerge about the availability of COVID-19 vaccines and how they will be administered, the role that payers will play in the process is becoming clearer, AIS Health reported. It's imperative for health plans to do two key things at the same time, according to Katherine […]
Drug Wholesale Prices Impact Payer Spending, Out-of-pocket Costs
Increases in drug wholesale list prices have a trickle-down effect that negatively impacts patient financial responsibility, such as out-of-pocket costs, and payer spending, according to a study published in JAMA Network Open. In recent years, the pharmaceutical industry has been scrutinized for […]
Use of Real-world Evidence in Economic Assessments of Pharmaceuticals in the US
In a recent study, investigators from the University of Washington School of Pharmacy reviewed cost-effectiveness and budget impact analyses in final evidence reports of pharmaceuticals published by ICER, calculating total number of RWE uses and the proportion of model inputs informed by RWE per […]
How Healthcare is Leveraging Real-World Data to Improve Outcomes
To improve outcomes during the COVID-19 pandemic and beyond, organizations are using real-world data for efficient and effective decision-making. At a time like this, researchers and leaders have to look beyond time-intensive, expensive randomized controlled trials. In order to find the answers to a […]
Scientist.com Reflects on the Resounding Successes of 2020
As 2020 comes to a close, we'd like to thank you for supporting our mission here at Scientist.com. Whether you have recently joined the marketplace or have been a part of the network for years, we are honored to have you as part of a community dedicated to creating Faster Science. Looking back on […]
Employee Health Data Analyses Must Include Race And Ethnicity
As the COVID-19 pandemic has highlighted, at the core of racial equity and social justice movements are health disparities along racial and ethnic lines. Health inequities can be addressed in the workplace through access to culturally sensitive programs and equitable health benefits for all […]
[On-demand Conference] Real World Evidence: Meet the Future with Confidence
COVID-19 is impacting all of us and challenging previous ways of working. This is a period of disruption. In this new reality, RWE will take a more prominent role to improve patient outcomes, meet stakeholder needs, and answer business questions. Join Pharmaceutical Executive®, IQVIA, and leading […]
NICE Updates Methods for Health Technology Evaluations
On November 6, 2020, NICE published a summary of its proposed changes to health technology evaluation methods. NICE periodically assesses its methods to optimize the process and ensure it can support rapid access to clinically- and cost-effective technologies. Within the scope of this process, […]
ICER Analytics™ Launched to Accelerate the Real-World Application of ICER Reports
Last month, saw the launch of ICER Analytics, a new cloud-based platform that will revolutionize the ability of payers, life science companies, patient groups, and others to develop formularies, negotiate drug prices, and explore new ways to apply evidence in a drive toward a health system that can […]
eBook: The role of RWE in FDA approvals
As industry prepares for the FDA’s draft RWE guidance in 2021, Aetion conducted a systematic review of FDA approval documents in 2019 to understand what role RWE plays in informing regulatory decisions. This eBook will guide you through when, where, and how RWE studies have supported the approvals […]
ICER Publishes Final Evidence Report for Bladder Cancer Therapies
The Institute for Clinical and Economic Review (ICER) today released a Final Evidence Report and Report-at-a-Glance assessing the comparative clinical effectiveness and value of nadofaragene firadenovec (Adstiladrin®, FKD Therapies Oy and FerGene) and oportuzumab monatox (Vicineum™, Sesen Bio) for […]
PRECISIONxtract Increasing Life Sciences Commercialization Capabilities
PRECISIONxtract, a Precision Value & Health team, announced the launch of two new and innovative product lines, EHR Connect™ and Access Genius™. These best-in-class solutions enable life science clients to achieve new levels of HCP engagement through leveraging sophisticated strategies, enhanced […]
Addressing the Affordability Crisis of Cell & Gene Therapies
In a recent Reuters Events poll, 43% of pharma said that reimbursement policy and legislation (e.g Best Price) is the most significant challenge in addressing market access issues related to cell and gene therapies. While there are indeed many common goals amongst pharma and healthcare when it comes […]
GoodRx Adds Telehealth and Mail-delivery
GoodRx, announced this morning that it was adding telehealth and mail-delivery to its subscription savings program, called GoodRx Gold, giving members access to the same free medication delivery that Amazon now advertises for its Prime subscription members, plus discounts on telehealth visits. […]
RxAdvance’s Sculley: What the PBM of the Future Might Look Like
The traditional models for pharmacy benefit managers have been under particular scrutiny of late, with these companies seeing the revival and finalization of the dreaded "rebate rule" and a Supreme Court ruling that could open the door for greater regulation. With these increasing calls for […]
Identifying High-Risk COVID Patients Through Early Symptoms and Other Risk Factors
As cases of the coronavirus continue to rise in the US and globally, there is increasing need to find more efficient ways to identify at-risk populations and find potential solutions to protect people from symptom onset. In a recent study, Nancy A Dreyer, chief scientific officer and senior vice […]
Digital Health Outcomes partners with the Institute for Clinical and Economic Review (ICER)
We are celebrating the launch of the next generation interactive modelling platform! Many thanks to our clients and partners, especially those who were the early adopters of our technology solutions for #healtheconomics ICER press release – https://lnkd.in/ewkzUTE Digital Health Outcomes home […]
Scientist.com to Acquire HealthEconomics.Com, the World’s Leading Connected Community for Health Economics and Outcomes Research
Scientist.com, the healthcare industry’s leading marketplace for outsourced R&D, announced today it will acquire HealthEconomics.Com, a private US-based company that has spent the last 25 years creating a global Connected Community™ of scientists and suppliers of health economics and outcomes […]
[Podcast] A Prescription for Fair Drug Pricing
ICER has announced the launch of a new podcast series entitled “A Prescription for Fair Drug Pricing.” In this series ICER’s President Dr. Steve Pearson sits with neurologist Dr. Jason Crowell as they try to better understand and unpack the financial and ethical tensions underpinning the US […]
